FDA Panel Rejects Avastin for Breast Cancer:
Interpreting results
Wall Street Journal
Expert Summary
How could the FDA panel reject a drug that helps to slow the spread of cancer? This nice article helps make sense of the research results and the FDA's decision.
Deanna Durica
Expert Scorecard
Overall Expert Score
Community Reviews
Overall Community Rating:
(3 reviews)
Anonymous
01/17/2008
Good article with several links included that points to some more good information to read. Best written of the three posted here. Comments posted at the bottom which make for interesting reading
Anonymous
12/04/2008
Anonymous
12/04/2008
Add your rating:
click to select